ADC Therapeutics SA logo
ADC Therapeutics SA ADCT
$ 3.78 -0.53%

Annual report 2022
added 12-21-2024

report update icon

ADC Therapeutics SA Market Cap 2011-2026 | ADCT

As of April 05, 2026 ADC Therapeutics SA has a market cap of $ 105 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap ADC Therapeutics SA

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 1.22 B 2.19 B - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.19 B 1.22 B 1.71 B

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
315 M - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
16.7 M - -24.86 % $ 820 K usaUSA
AbbVie AbbVie
ABBV
400 B $ 208.84 -2.86 % $ 369 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
962 M $ 3.52 0.28 % $ 1.05 B canadaCanada
Grifols, S.A. Grifols, S.A.
GRFS
8.42 B $ 8.24 -0.12 % $ 6.83 B spainSpain
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
7.37 B $ 229.25 0.44 % $ 5 B danmarkDanmark
I-Mab I-Mab
IMAB
127 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
33.6 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
168 B - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
549 M - -13.47 % $ 169 M franceFrance
Aeterna Zentaris Aeterna Zentaris
AEZS
41.4 M - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
724 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
32.8 M - - $ 26.5 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
3.25 B - - $ 3.67 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
79 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
28.9 M - -1.52 % $ 24.7 M usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
1.2 B $ 74.21 -2.3 % $ 1.43 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
76.4 M - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
1.87 M - -9.65 % $ 45.9 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
322 M $ 1.41 2.17 % $ 375 M britainBritain
AgeX Therapeutics AgeX Therapeutics
AGE
14.1 K - -10.17 % $ 12.2 K usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
11.4 M $ 1.51 48.04 % $ 17 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
22.1 M - - $ 10.1 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
19.6 M - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
172 M - 0.23 % $ 488 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.83 B - - - russiaRussia
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
71.4 M - 3.16 % $ 1.9 M usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
11.7 B $ 55.5 -3.04 % $ 10.6 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
269 M - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
38.2 M - 10.36 % $ 9.8 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
217 M $ 8.03 2.29 % $ 220 M israelIsrael
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
2.48 B $ 14.81 2.63 % $ 2.25 B usaUSA
Altimmune Altimmune
ALT
318 M $ 3.34 7.05 % $ 294 M usaUSA
BioNTech SE BioNTech SE
BNTX
62.9 B $ 91.18 1.97 % $ 27.2 B germanyGermany
Amgen Amgen
AMGN
198 B $ 347.94 -1.51 % $ 187 B usaUSA
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
1.86 B $ 15.61 0.9 % $ 2.1 B canadaCanada
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
122 B $ 59.6 -2.45 % $ 121 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
2.32 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
9.48 M - -39.0 % $ 4.57 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.53 B - - $ 867 M germanyGermany
Burford Capital Limited Burford Capital Limited
BUR
2.09 B $ 4.14 -2.59 % $ 683 M britainBritain
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
1.72 B $ 9.02 -3.84 % $ 1.86 B usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
544 K - -52.27 % $ 4.45 M usaUSA
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
426 M $ 5.76 1.95 % $ 469 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
253 B - 0.49 % $ 251 B cayman-islandsCayman-islands
AVROBIO AVROBIO
AVRO
56.3 M - 1083.1 % $ 745 M usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
203 M $ 3.41 1.19 % $ 116 M franceFrance
Biogen Biogen
BIIB
29.4 B $ 177.34 -3.5 % $ 26 B usaUSA
Axcella Health Axcella Health
AXLA
25 M - -16.42 % $ 249 M usaUSA
Axon Enterprise Axon Enterprise
AXON
39.8 B $ 412.81 -2.54 % $ 31.3 B usaUSA